Pfizer pours $25m into Vedanta’s Phase II IBD study January 19, 2021 Auto Bot Clinical Development 0 The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciencesâ VE202 inflammatory bowel disease treatment candidate.
